Predictive value of preoperative peripheral lymphocyte count on recurrence of resectable non-small cell lung cancer

被引：2
|
作者：
Zhang, Jian
Huang, Shaohong
Li, Hui
Chen, Xiuling
Li, Yun
Wang, Cuiping
Gu, Lijia
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Thorac Surg, Guangzhou 510275, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 3, Clin Res Ctr Thorac Oncol, Guangzhou 510275, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 30期
关键词：
D O I：
10.1200/jco.2012.30.30_suppl.81
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
81
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Preoperative biopsy does not affect postoperative outcomes of resectable non-small cell lung cancer
    Yohei Taniguchi
    Kento Fukumoto
    Hiroshi Matsui
    Tomohito Saito
    Tomohiro Murakawa
    General Thoracic and Cardiovascular Surgery, 2019, 67 : 615 - 623
  • [12] Preoperative biopsy does not affect postoperative outcomes of resectable non-small cell lung cancer
    Taniguchi, Yohei
    Fukumoto, Kento
    Matsui, Hiroshi
    Saito, Tomohito
    Murakawa, Tomohiro
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2019, 67 (07) : 615 - 623
  • [13] Preoperative Bevacizumab in Combination With Paclitaxel and Carboplatin in Surgically Resectable Non-Small Cell Lung Cancer
    Bertino, Erin
    Villalona-Calero, Miguel A.
    Ross, Patrick
    Grever, Michael
    Otterson, Gregory A.
    ANNALS OF THORACIC SURGERY, 2011, 91 (02): : 640 - 640
  • [14] THE CLINICAL VALUE OF MEDIASTINOSCOPY IN PREOPERATIVE STAGING OF NON-SMALL CELL LUNG CANCER
    Kim, D.
    Jin, H. Seok
    Hyochae, P.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S66 - S66
  • [15] KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer
    I. Sullivan
    J. Salazar
    C. Arqueros
    M. Andrés
    A. Sebio
    M. Majem
    J. Szafranska
    E. Martínez
    D. Páez
    A. López-Pousa
    M. Baiget
    A. Barnadas
    Clinical and Translational Oncology, 2017, 19 : 884 - 890
  • [16] KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer
    Sullivan, I.
    Salazar, J.
    Arqueros, C.
    Andres, M.
    Sebio, A.
    Majem, M.
    Szafranska, J.
    Martinez, E.
    Paez, D.
    Lopez-Pousa, A.
    Baiget, M.
    Barnadas, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (07): : 884 - 890
  • [17] The clinical value of the changes of peripheral lymphocyte subsets absolute counts in patients with non-small cell lung cancer
    Xia, Ying
    Li, Wentao
    Li, Yongmin
    Liu, Yunhe
    Ye, Songshan
    Liu, Aqing
    Yu, Jianchun
    Jia, Yingjie
    Liu, Xu
    Chen, Huayu
    Guo, Yongtie
    TRANSLATIONAL ONCOLOGY, 2020, 13 (12):
  • [18] A Paradigm Shift for Resectable Non-Small Cell Lung Cancer
    Isla, Dolores
    Majem, Margarita
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (12): : 792 - 793
  • [19] Adjuvant treatment for resectable non-small cell lung cancer
    Lim, Jeong Uk
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2023, 66 (03): : 173 - 179
  • [20] Immunotherapy in surgically resectable non-small cell lung cancer
    Owen, Dwight
    Chaft, Jamie E.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S404 - S411
12345